Lessons From Astaxanthin Therapy to Combat Oral Premalignant and Malignant Lesions: A Narrative Review
Health Science Reports · 2026-07 · 9 (7)
DOI: 10.1002/hsr2.72712 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 30.06.2026. Verfasst von Reza Arefnezhad und 12 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee Fasa University of Medical Sciences Fasa Iran. Die Arbeit nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background and Aims Oral cancer is one of the most common head and neck malignancies and remains associated with high morbidity, mortality, and treatment‐related toxicity. Despite advances in surgery, radiotherapy, and chemotherapy, there is still a need for safer adjunctive therapies with better therapeutic potential.
Results
Astaxanthin, a natural lipophilic carotenoid, has gained attention because of its antioxidant, anti‐inflammatory, and anticancer activities. The available evidence suggests that astaxanthin may suppress oral premalignant and malignant progression by inhibiting inflammation, oxidative stress, proliferation, invasion, angiogenesis, and survival signaling pathways, while promoting apoptosis and reactivating tumor suppressor mechanisms. Preclinical studies also indicate that astaxanthin‐based formulations may improve delivery efficiency and enhance antitumor effects in oral cancer models.
Conclusion
Overall, astaxanthin appears to be a promising natural candidate for oral cancer prevention and treatment. However, most findings are based on preclinical studies, and further well‐designed clinical investigations are required to confirm its efficacy and safety.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Student Research Committee Fasa University of Medical Sciences Fasa Iran.
- Student Research Committee Shiraz University of Medical Sciences Shiraz Iran.
- Faculty of Medicine Kermanshah University of Medical Sciences Kermanshah Iran.
- Shiraz Dental School Shiraz University of Medical Sciences Shiraz Iran.
- Registered Dental Hygienist Vancouver British Columbia Canada.
- Department of Dermatology, School of Medicine, Rasool Akram Medical Complex Iran University of Medical Sciences (IUMS) Tehran Iran.
ORCID-Profile: Fatemeh Rezaei-Tazangi
Zitieren
APA
Arefnezhad, R., Mohamadi, Z., Shahianjahromi, S., Fallahian, A., Ashrafi, M., Nikdehqan, A., Valashani, M. S., Nasiri, R., Zeinali, F., Fatemian, H., Sefati, N., Rezaei-Tazangi, F., & Tavakoli, M. R. (2026). Lessons From Astaxanthin Therapy to Combat Oral Premalignant and Malignant Lesions: A Narrative Review. Health Science Reports, 9(7). https://doi.org/10.1002/hsr2.72712
Vancouver
Arefnezhad R, Mohamadi Z, Shahianjahromi S, Fallahian A, Ashrafi M, Nikdehqan A, et al. Lessons From Astaxanthin Therapy to Combat Oral Premalignant and Malignant Lesions: A Narrative Review. Health Science Reports. 2026;9(7). doi:10.1002/hsr2.72712
BibTeX
@article{Arefnezhad2026,
author = {Arefnezhad, Reza and Mohamadi, Zhina and Shahianjahromi, Shervin and Fallahian, Amirali and Ashrafi, Maryam and Nikdehqan, Armin and Valashani, Mitra Saeedi and Nasiri, Reza and Zeinali, Fatemeh and Fatemian, Hossein and Sefati, Niloofar and Rezaei-Tazangi, Fatemeh and Tavakoli, Marziye Ranjbar},
title = {Lessons From Astaxanthin Therapy to Combat Oral Premalignant and Malignant Lesions: A Narrative Review},
journal = {Health Science Reports},
year = {2026},
volume = {9},
number = {7},
doi = {10.1002/hsr2.72712}
}
EUVIMED